Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport

Table 3

Clinical outcome endpoints of both study groups (mean ± SD and median).

	Group 1 (n = 156)	Group 2 (n = 65)	value
Duration of MV^a during ICU^b stay (days, mean ± SD)	18 (2–48)	24 (1–62)	0.078
Days without MV (ventilation-free days) (days, mean ± SD)	2.81 ± 3.591	2.95 ± 4.488	0.799
Patients weaned from MV, no. (%)	62.2%	63.1%	0.513
Length of ICU stay (days, mean ± SD)	22 (5–52)	27 (4–66)	0.108
Length of hospital stay (days, mean ± SD)	32.5 (11–75)	40 (9–82)	0.31
ICU mortality (%)	32.1%	29.2%	0.68
Intrahospital mortality (after discharge from ICU)
(%)	0	1.9%	0.26

Group 1: critically ill patients who were not transported outside of the ICU during their hospitalization period. Group 2: critically ill patients who were transported outside of the ICU during iNO treatment during their hospitalization period Data are considered statistically significant if . ^aMV: mechanical ventilation. ^bICU: intensive care unit.